Friday, July 28, 2017 7:19:41 PM
MassRoots was rejected by Nasdaq - "Nasdaq determined that listing the company could have been seen as aiding the distribution of an illegal substance, MassRoots said."
GWP has over 40 cannabis related patents - has FDA approval to FastTrack Epidiolex. Plus many more patents in the pipeline.
GWP has some patents that could have a deleterious effect on the Mom and Pop operations like TRTC - actually the entire industry.
Be watching for Greenwich Biosciences, Inc.
But there is a huge difference between GWP and a company selling weed.
Any product that GWP sells is manufactured to the FDA standards - TRTC is selling edibles that of uneven quality - they have no manufacturing requirements that are close to the pharmaceutical industry.
IG
"Straight Facts Homey!"
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM